Rimactazid Paed 60/60

Rimactazid Paed 60/60 is a medication primarily used in the treatment of tuberculosis (TB) in pediatric patients. It contains two active ingredients: rifampicin and isoniazid. Rifampicin is an antibiotic that works by inhibiting the growth of the TB bacteria, while isoniazid is an antimycobacterial agent that prevents the TB bacteria from multiplying.

Dosage and Administration:

The dosage of Rimactazid Paed 60/60 depends on the weight of the child and should be determined by a healthcare professional. The recommended dosage is usually calculated based on the child’s body weight, with a typical dose of 10 mg/kg of rifampicin and 5 mg/kg of isoniazid per day. However, the exact dosage may vary depending on the specific treatment regimen and the severity of the TB infection.

Rimactazid Paed 60/60 is usually administered orally as a tablet or in a suspension form. It is important to follow the instructions provided by the healthcare professional or the medication’s packaging for proper administration. The medication is commonly taken once daily, preferably on an empty stomach or 1-2 hours after a meal, with a glass of water.

Duration of Treatment:

The duration of treatment with Rimactazid Paed 60/60 for tuberculosis can vary depending on the specific circumstances and severity of the infection. Generally, treatment can last for several months or even up to a year. It is crucial to complete the full course of treatment as prescribed by the healthcare professional, even if the symptoms improve or disappear earlier.

Possible Side Effects:

Rimactazid Paed 60/60 may cause some side effects in pediatric patients. Common side effects include:

1. Gastrointestinal symptoms: Nausea, vomiting, abdominal pain, and loss of appetite.
2. Skin reactions: Rash, itching, and increased sensitivity to sunlight.
3. Liver problems: Elevated liver enzymes, hepatitis, or jaundice.

It is essential to report any unusual or severe side effects to the healthcare professional overseeing the treatment.

Precautions:

Before starting Rimactazid Paed 60/60, inform the healthcare professional about any pre-existing medical conditions or allergies the child may have. Additionally, disclose any other medications, including over-the-counter drugs and supplements, to avoid potential interactions.

Rimactazid Paed 60/60 may interact with other medications, such as oral contraceptives, anticoagulants, and certain antiretroviral drugs. The healthcare professional will assess any potential interactions and adjust the treatment regimen accordingly.

In conclusion, Rimactazid Paed 60/60 is a medication used in the treatment of tuberculosis in pediatric patients. It contains rifampicin and isoniazid as active ingredients. The dosage is determined by the child’s weight and should be administered once daily. It is important to complete the full course of treatment as prescribed. Common side effects may include gastrointestinal symptoms, skin reactions, and liver problems. Consult a healthcare professional for specific dosing instructions and to monitor for potential interactions or adverse effects.